The Use of Corticosteroids in Childhood Asthma

References

• Carryer HM, Koelsche GA, Prickman LE. The effects of cortisone on bronchial asthma and hay fever occurring in subjects sensitive to ragweed pollen. J Allergy 1986; 21: 282
   Google Scholar
• Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981; 36: 575–579
   PubMed Web of Science ®Google Scholar
• Yan K, Salome CM, Woolcock AJ. Rapid method for measurement of bronchial hyperresponsiveness. Thorax 1983; 38: 760–765
   PubMed Web of Science ®Google Scholar
• Dunhill MS. The pathology of asthma with special reference to changes in bronchial mucosa. J Clin Pathol 1960; 13: 21
   Google Scholar
• Laitinen LA., Heino M, Laitinen A. Damage of the airway epithelium and bronchial reactivity patients with asthma. Am Rev Respir Dis 1985; 131: 599–606
   PubMed Web of Science ®Google Scholar
• Dunhill MS. The pathology of asthma, Middleton E Allergy, Jr, CE Reed, EF Ellis. CV Mosby, St. Louis 1978; 678–686
   Google Scholar
• Naylor B. The shedding of the mucosa of the bronchial trees in asthma. Thorax 1962; 17: 69–72
   PubMedGoogle Scholar
• Adelroth E, Morris MM, Hargreave FE, O'Byrne PM. Airway responsiveness to leukotrienes C4and D4 and to methacholine in patients with asthma and normal controls. X Engl J Med 1986; 3
   Google Scholar
• Goetzl EJ, Payan DG, Goldman DW. Immune-pathogenetic roles of leukotrienes in human diseases. J Clin Immunol 1984; 4: 79–84
   PubMed Web of Science ®Google Scholar
• Marom Z, Shelhamer JH, Bach MK. Slow-reacting substances, leukotrienes C4 and D4 increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982; 726: 449–451
   Google Scholar
• Martin TR, Altman LC, Albert RK, Henderson WR. Leukotriene B4 production by the human alveolar macrophage: A potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis 1984; 129: 106–111
   PubMed Web of Science ®Google Scholar
• Hardy CC, Robinson C, Tattersfield AE, Holgate ST. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. X Engl J Med 1984; 3/1: 209–213
   Google Scholar
• Barnes PJ, Chung KF, Page CP. Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol 1988; 81: 919–934
   PubMed Web of Science ®Google Scholar
• Braquet P, Etienne A, Clostre F. Down regulation of beta2-adrenergic receptors by PAF-acether and H2 inhibition by the PAF-acether antagonist BN 52021. Prostaglandins 1985; 30: 721–726
   Google Scholar
• Henocq E, Vargaftig BB. Accumulation of eosinophils in response to intracutaneous PAF- acether and allergens in man. Lancet 1986; i: 1378–1379
   Google Scholar
• Chung KF. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 1986; 41: 657–662
   PubMed Web of Science ®Google Scholar
• Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986; 77: 527–537
   PubMed Web of Science ®Google Scholar
• Frigas E, Loegering DA, Solley GO. Elevated levels of the eosinophil granule major base protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 1981; 56: 345–353
   PubMed Web of Science ®Google Scholar
• Wardlaw AJ, Dunette S, Gleich GJ. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988; 137: 62–69
   PubMed Web of Science ®Google Scholar
• Gleich GJ, Frigas E, Loegering DA. Cytotoxic properties of the eosinophil major basic protein. J Immunol 1979; 123: 2925–2927
   PubMed Web of Science ®Google Scholar
• Aizawa H, Miyazaki N, Shigeatsu M, Tomooka M. A possible role of airway epithelium in modulating hyperresponsiveness. Br J Pharmacol 1988; 93: 139–145
   PubMed Web of Science ®Google Scholar
• Kehrl JH, Fauci AS. The clinical use of gluco corticoids. Ann Allergy 1983; 50: 2–8
   Google Scholar
• Blackwell GJ, Carnvcciok DiRosa M. Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. Ad Prostaglamt Thmm Leuko Res 1983; 11: 65
   Google Scholar
• Galant SP, Duriseti L, Underwood S, Insel DA. Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. X Engl J Med 1978; 299: 933–936
   PubMed Web of Science ®Google Scholar
• Weber RW., Smith JA, Nelson HS. Aerosolized ter butaline in asthmatics: Development of subsensi-tivity with long-term administration. J Allergy Clin Immunol 1982; 70: 417–422
   Google Scholar
• Mano K, Akbarzadeh A, Townley RG. Effect of hydrocortisone on beta-adrenergic receptors in lung membranes. Life Sci 1925-1930; 25, 1979
   Google Scholar
• Davies AO, Lefkowitz RJ. In vitro desensitization of beta adrenergic receptors in human neutrophils. Attenuation by corticosteroids. J Clin Invi-si 1983; 71: 565–571
   PubMed Web of Science ®Google Scholar
• Sly RM. Adverse effects and complications of treatment with beta-adrenergic agonist drugs. 1. Allergy Clin Immunol 1985; 75: 443–449
   Google Scholar
• Pierson WE, Bierman CW, Kelley VC. A double-blind trial of corticosteroid therapy in status asthmaticus. Pediatrics 1974; 54: 282, 288
   PubMed Web of Science ®Google Scholar
• Younger RE, Gerber PS, Henod HG. Intravenous mrthylprednisolono efficacy in statu-asthmaticus of childhood. Pediatrics 1987; 80: 225–230
   Google Scholar
• Loren ML, Hyman C, Leung P. Corticosteroids in the treatment of acute exacerbations of asthma. Ann Allergy 1980; 45: 67–71
   Google Scholar
• Harris JB, Weinberger MM., Nassif E. Early intervention with short courses of prednisolone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilutors. J Pediatr 1987; 110: 627–633
   PubMed Web of Science ®Google Scholar
• Zora JA, Zimmerman D, Carey TL. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 1986; 77: 9–13
   PubMed Web of Science ®Google Scholar
• Shapiro GG, Tattoni DS, Kelley VC. Growth. pulmonary, and endocrine function in chronic asthmatic patients on daily and alternate dav adrenocorticosteroid therapy./. Allergy Clin Immunol 1976; 57: 430–439
   Google Scholar
• Morris HG, Neuman I, Ellis EF. Plasma steroid concentrations during alternate-day treatment with prednisone. J Allergy Clin Immunol 1974; 54: 350–358
   Web of Science ®Google Scholar
• Wyatt R, Waschek J, Weinberger M, Sherman B. Effects of inhaled beclomethasone dipropionate and alternate day prednisone on pit uitary-adrenal tunc tion in children with chronic asthma. X Engl J Med 1978; 299: 1387–1392
   PubMed Web of Science ®Google Scholar
• Morris HG, Jorgenson JR. Recovery of endogenous pituitary-adrenal function in corticosteroid treated children. J Pediatr 1971; 79: 480, 488
   Google Scholar
• Nassif E, Weinberger M, Sherman B, Brown K. Kx tra pulmonary effects of maintenance corticosteroid therapy with alternate day prednisone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol 1987; 80: 518–529
   PubMed Web of Science ®Google Scholar
• Chesney RW, Mazess RB, Rose P, Jax DK. Effect of prednisone on growth and bone mineral content in childhood glomerular disease. Am J Dis Child 1978; 732: 768–772
   Google Scholar
• Klein R, Waldman D, Keishnar H. Treatment of chronic childhood asthma with beclomethasone dipropionate aersol. A double-blind crossover trial in nonsteroid-dependent patients. Pediatrics 1977; 60: 7–13
   PubMed Web of Science ®Google Scholar
• Shapiro GG, Izu AE, Furakawa CT. Short-term double-blind evaluation of flunisolide aerosol for steroid-dependent asthmatic children and adolescents. Chest 1981; 80: 671–675
   Google Scholar
• Sly RM, Imseis M, Frazer M. Treatment of asthma in children with triamcinolone acetonide aerosol. J Allergy Clin Immunol 1978; 62: 76–82
   PubMed Web of Science ®Google Scholar
• Kraemer K, Seonhauser F, Reinhardt M. Effects of regular inhalation of beclomethasone dipropionate and sodium cromoglycate on bronchial hyperreactivity in asthmatic children. ACTA Paediatr Scand 1987; 76: 119–123
   PubMed Web of Science ®Google Scholar
• Soderbert-Warner M, Siegel S, Katz R. Treat ment of chronic childhood asthma with beclometha sone dipropionate aerosol: long term effects on growth. J Allergy Clin Immunol. 1979; 63: 164
   Google Scholar
• Godfrey S, Balfour-Lynn L, Tooley M. A three to five year follow-up of the use of aerosol steroid, beclo methasone dipropionate, in childhood asthma. J Allergy Clin Immunol 1978; 62: 335, 339
   PubMed Web of Science ®Google Scholar
• Goldstein DE, Konig P. Effect of inhaled beclomethasone dipropionate on hvpothalamic-pituitarv-adrenal axis function in children with asthma. Pediatrics 1983; 72: 60–64
   PubMed Web of Science ®Google Scholar
• Harrison BOW., Rees LH., Cavton RM, Nabarro JDN. Recovery of hypothalamic-pituitary-adrenal function in asthmatics whose oral steroid have been stopped or reduced. Clin Endocrinol 1982; 17: 109–118
   Google Scholar
• Wilson KS, Gray CE, Lidgard CE, Parker AC. Postgrad Med 1977; 53: 745
   Google Scholar
• Mellis CM, Phelan PD. Asthma deaths in children a continuing problem. Thorax 1977; 32: 29–34
   PubMed Web of Science ®Google Scholar
• Dolan LM, Kesarwala HH, Holroyde JC, Fischer TJ. Short-term, high-dose, systemic -teroids in children with asthma: The effect on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol 1987; 80: 81–87
   Google Scholar
• Vaz R, Senior B, Morris M. Adrenal effects of beclomethasone inhalation therapy in asthmatic children. J Pediatr 1982; 700: 660, 662
   Google Scholar
• Law CM, Marchant JL, Honouk JW. Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet 1986; 942–944
   Google Scholar